ObsEva SA (OBSV) stock forecast for 2022. Forecast tables and graphs.

ObsEva SA (OBSV) stock forecast for 2022

The forecast has been updated: September 20, 2021 18:00


ObsEva SA stock price online today

Analyst Target Price

16.67

Dividend Date

-

Ex Dividend Date

-

Last Split Factor

None

Last Split Date

-

Should you buy or sell ObsEva SA stock stock today? What is the projected target price level for 2022? How much will it cost in 2022? ObsEva SA stock Stock Monthly Prediction for January, February, March, April, May, July, July, August, September, October, November and December 2022.

We predict the dynamics of the stock market value using resonant artificial intelligence systems.

Technical, fundamental analyzes, news background, general geopolitical situation in the world and other factors are taken into account.

Forecasts are adjusted once a day taking into account the price change of the previous day.

To date, analysts have a $16.67 target price for ObsEva SA stock stock.

Today 200 Day Moving Average is the support level (2.945 $).

50 Day Moving Average is the support level (2.829 $).




OBSV Forecast for 2022

Month Rate Forecast MIN Rate MAX Rate Volati-
lity, %
Jan 3.82 3.45 4.25 18.78 %
Feb 3.32 3.08 3.64 15.59 %
Mar 3.57 3.10 3.85 19.51 %
Apr 4.17 3.73 4.65 19.85 %
May 4.19 3.83 4.66 17.81 %
Jun 4.31 3.69 4.90 24.70 %
Jul 4.86 4.22 5.57 24.23 %
Aug 5.19 5.00 5.49 8.85 %
Sep 5.19 4.67 5.90 20.90 %
Oct 5.53 4.82 6.05 20.41 %
Nov 5.61 5.15 6.07 15.15 %
Dec 5.77 5.30 6.40 17.19 %

The forecasts table above shows the forecast values of the company's stock price for each month. The Rate Forecast column displays the Optimal Average Forecast Price. The MIN Rate column displays a pessimistic forecast for this month. “MAX Rate” is an optimistic forecast. The % Volatility column represents the approximate monthly volatility of ObsEva SA stock.


ObsEva SA overview

ObsEva SA Address

CHEMIN DES AULX, 12, PLAN-LES-OUATES, CH

Market Capitalization

260 354 000 $

EBITDA

-98 566 000

PE Ratio

None

PEG Ratio

0

Dividend Per Share

None

Dividend Yield

0

EPS

-1.312

Quarterly Earnings Growth YOY

0

Quarterly Revenue Growth YOY

0.5

Trailing PE

0

Forward PE

0

EV To Revenue

0

EV To EBITDA

0

52 Week High

5.15

52 Week Low

1.855

50 Day Moving Average

2.829

200 Day Moving Average

2.945

Shares Outstanding

77950000

Shares Float

58144000

Shares Short Prior Month

1488500

Short Ratio

1.72

Percent Insiders

6.8

Percent Institutions

39.37

ObsEva SA stock forecast for this year


ObsEva SA stock forecast for Jan 2022.
Estimated Average Forecasted ObsEva SA Price: 3.82. Positive monthly dynamics of the instrument is expected with 18.784% volatility is expected.

Pessimistic forecast: 3.45

Optimistic: 4.25


ObsEva SA stock forecast for Feb 2022.
Estimated Average Forecasted ObsEva SA Price: 3.32. Negative monthly dynamics of the instrument is expected with 15.585% volatility is expected.

Pessimistic forecast: 3.08

Optimistic: 3.64


ObsEva SA stock forecast for Mar 2022.
Estimated Average Forecasted ObsEva SA Price: 3.57. Positive monthly dynamics of the instrument is expected with 19.514% volatility is expected.

Pessimistic forecast: 3.10

Optimistic: 3.85


ObsEva SA stock forecast for Apr 2022.
Estimated Average Forecasted ObsEva SA Price: 4.17. Positive monthly dynamics of the instrument is expected with 19.853% volatility is expected.

Pessimistic forecast: 3.73

Optimistic: 4.65


ObsEva SA stock forecast for May 2022.
Estimated Average Forecasted ObsEva SA Price: 4.19. Positive monthly dynamics of the instrument is expected with 17.812% volatility is expected.

Pessimistic forecast: 3.83

Optimistic: 4.66


ObsEva SA stock forecast for Jun 2022.
Estimated Average Forecasted ObsEva SA Price: 4.31. Positive monthly dynamics of the instrument is expected with 24.701% volatility is expected.

Pessimistic forecast: 3.69

Optimistic: 4.90


ObsEva SA stock forecast for Jul 2022.
Estimated Average Forecasted ObsEva SA Price: 4.86. Positive monthly dynamics of the instrument is expected with 24.231% volatility is expected.

Pessimistic forecast: 4.22

Optimistic: 5.57


ObsEva SA stock forecast for Aug 2022.
Estimated Average Forecasted ObsEva SA Price: 5.19. Positive monthly dynamics of the instrument is expected with 8.850% volatility is expected.

Pessimistic forecast: 5.00

Optimistic: 5.49


ObsEva SA stock forecast for Sep 2022.
Estimated Average Forecasted ObsEva SA Price: 5.19. Negative monthly dynamics of the instrument is expected with 20.901% volatility is expected.

Pessimistic forecast: 4.67

Optimistic: 5.90


ObsEva SA stock forecast for Oct 2022.
Estimated Average Forecasted ObsEva SA Price: 5.53. Positive monthly dynamics of the instrument is expected with 20.410% volatility is expected.

Pessimistic forecast: 4.82

Optimistic: 6.05


ObsEva SA stock forecast for Nov 2022.
Estimated Average Forecasted ObsEva SA Price: 5.61. Positive monthly dynamics of the instrument is expected with 15.153% volatility is expected.

Pessimistic forecast: 5.15

Optimistic: 6.07


ObsEva SA stock forecast for Dec 2022.
Estimated Average Forecasted ObsEva SA Price: 5.77. Positive monthly dynamics of the instrument is expected with 17.192% volatility is expected.

Pessimistic forecast: 5.30

Optimistic: 6.40



Other Healthcare sector assets

Name Symbol Last Close Price Change
Abbott Laboratories
ABT 124.37 (24.09.2021) -0.74 %
AbbVie Inc.
ABBV 107.07 (24.09.2021) -0.27 %
Aeterna Zentaris Inc.
AEZS 0.602564 (24.09.2021) -3.68 %
Allakos Inc.
ALLK 108.17 (24.09.2021) -2.05 %
Allogene Therapeutics, Inc.
ALLO 25.66 (24.09.2021) -7.16 %
Amgen Inc.
AMGN 213.61 (24.09.2021) -0.67 %
Aphria Inc.
APHA 15.38 (07.05.2021) 0.00 %
Atara Biotherapeutics, Inc.
ATRA 17 (24.09.2021) -1.73 %
Aurora Cannabis Inc.
ACB 5.95 (24.09.2021) -3.25 %
Becton Dickinson and Company
BDX 253.18 (24.09.2021) -0.25 %
Biogen Inc.
BIIB 291.71 (24.09.2021) -0.51 %
Biohaven Pharmaceutical Holding Company Ltd.
BHVN 133.38 (24.09.2021) -1.60 %
BioNTech SE
BNTX 333.48 (24.09.2021) -5.53 %
bluebird bio, Inc.
BLUE 18.44 (24.09.2021) -1.18 %
Boston Scientific Corp.
BSX 44.7 (24.09.2021) -0.67 %
Bristol-Myers Squibb Company
BMY 60.23 (24.09.2021) -0.66 %
Canopy Growth Corp.
CGC 13.91 (24.09.2021) -4.46 %
Castle Biosciences, Inc.
CSTL 72.44 (24.09.2021) -3.35 %
CLOVER HEALTH INVESTMENTS, CORP
CLOV 7.73 (24.09.2021) -2.15 %
Eli Lilly and Company
LLY 231.68 (24.09.2021) -0.22 %
Emergent BioSolutions Inc.
EBS 52.39 (24.09.2021) -2.69 %
Exelixis, Inc.
EXEL 20.35 (24.09.2021) -0.73 %
G1 Therapeutics, Inc.
GTHX 15.1 (24.09.2021) -1.44 %
Gilead Sciences, Inc.
GILD 71.19 (24.09.2021) -0.70 %
GlaxoSmithKline plc
GSK 38.39 (24.09.2021) -2.41 %
GoodRx Holdings, Inc.
GDRX 44.13 (24.09.2021) -4.75 %
GW Pharmaceuticals plc.
GWPH 218.96 (05.05.2021) 0.00 %
Incyte Corp.
INCY 69 (24.09.2021) -1.12 %
Inovio Pharmaceuticals, Inc.
INO 7.76 (24.09.2021) -3.36 %
Johnson & Johnson
JNJ 164.36 (24.09.2021) -0.30 %
Medtronic plc.
MDT 130.02 (24.09.2021) -0.47 %
Merck & Co., Inc.
MRK 73.61 (24.09.2021) 0.77 %
Moderna, Inc.
MRNA 430.14 (24.09.2021) -5.38 %
Novartis AG
NVS 82.93 (24.09.2021) -0.77 %
Novavax, Inc.
NVAX 248.16 (24.09.2021) -3.55 %
ObsEva SA
OBSV 3.15 (24.09.2021) -0.32 %
OrganiGram Holdings Inc.
OGI 2.42 (24.09.2021) -3.20 %
Pfizer Inc.
PFE 43.94 (24.09.2021) -0.57 %
Regeneron Pharmaceuticals, Inc.
REGN 638.9 (24.09.2021) -1.18 %
Sanofi
SNY 47.94 (24.09.2021) -1.60 %
Schrodinger, Inc.
SDGR 57.95 (24.09.2021) -4.23 %
Senseonics Holdings, Inc.
SENS 3.57 (24.09.2021) -4.29 %
Sorrento Therapeutics, Inc.
SRNE 7.83 (24.09.2021) -3.09 %
Stryker Corp.
SYK 276.64 (24.09.2021) 0.17 %
Sundial Growers Inc.
SNDL 0.673 (24.09.2021) -4.06 %
Teva Pharmaceutical Industries Lim. (TEVA)
TEVA 8.95 (24.09.2021) -1.10 %
Thermo Fisher Scientific Inc.
TMO 609.78 (24.09.2021) 0.25 %
Tilray, Inc.
TLRY 11.67 (24.09.2021) -2.91 %
UnitedHealth Group, Inc.
UNH 407.08 (24.09.2021) -0.23 %
Veeva Systems Inc.
VEEV 299.93 (24.09.2021) 0.41 %
Zomedica Corp.
ZOM 0.5178 (24.09.2021) -2.30 %
Zynerba Pharmaceuticals, Inc.
ZYNE 4.46 (24.09.2021) -1.55 %


Denial of responsibility:

The portal leoprophet.com is not responsible for the loss of your money as a result of your use of the information contained on the site, including data, quotes, charts and forecasts. Operations in the stock, foreign exchange and commodity markets involve a high level of risk, and you are solely responsible for your operations. Only speculate with money that you can afford to lose. All prices and forecasts for stocks, indices, futures are indicative and should not be trade dependent. The portal is not responsible for any losses that you may incur as a result of using this data.